Our recent studies indicate that deficiency of the CCN5-driven program in BC promotes the growth of cancer cells and EMT, while upregulation of CCN5 is linked with ER-α-activation in both normal and cancer cells of human and mouse breast [44, 58]. This evidence concerns the gene CCN5 and cancer.